Global Non Alcoholic Steatohepatitis Biomarkers Market Report 2023: Market Size, Top Segments And Key Trends

Spread the love

The Non Alcoholic Steatohepatitis Biomarkers Global Market Report 2023, provides comprehensive information on the non alcoholic steatohepatitis biomarkers market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Non Alcoholic Steatohepatitis Biomarkers Market’s Growth:

https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-biomarkers-global-market-report

As per The Business Research Company’s Non Alcoholic Steatohepatitis Biomarkers Global Market Report 2023, the global non-alcoholic steatohepatitis biomarkers market size is expected to grow from $0.88 billion in 2022 to $1.10 billion in 2023 at a compound annual growth rate (CAGR) of 24.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global non-alcoholic steatohepatitis biomarkers market size is expected to grow to $2.54 billion in 2027 at a CAGR of 23.2%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=9002&type=smp

Technological advancements are a key trend in gaining popularity in the non-alcoholic steatohepatitis biomarkers market. Major companies operating in the non-alcoholic steatohepatitis biomarkers market are focused on developing innovative solutions to strengthen their position in the market. For instance, in October 2022, GENFIT, a France-based late-stage biopharmaceutical company, and LabCorp, a US-based life sciences company, agreed on a five-year exclusive licensing deal for GENFIT’s NIS4 technology to aid in identifying patients with non-alcoholic-steatohepatitis-at-risk (NASH). NIS4 technology is an innovative, multi-biomarker-based algorithm specifically developed to identify patients with non-alcoholic steatohepatitis (NASH) and significant to advanced fibrosis (F > 2), also referred to as at-risk NASH. As part of the agreement, LabCorp will develop and commercialize a blood-based molecular diagnostic test utilizing NIS4 technology in the United States and Canada, giving widespread access to healthcare professionals.

The non alcoholic steatohepatitis biomarkers market is segmented:

1) By Type: Hepatic Fibrosis Biomarkers, Serum Biomarkers, Oxidative Stress Biomarkers, Apoptosis Biomarkers, Other Types

2) By Disease: Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity

3) By End Use: Research Institutes And Academics, Diagnostic Centres, Pharmaceutical Companies And Pharmaceutical Companies And Contract Research Organizations (CROs), Hospitals And Clinics, Other End-Uses

North America was the largest region in the non alcoholic steatohepatitis biomarkers market in 2022.

The table of contents in TBRC’s non alcoholic steatohepatitis biomarkers market report includes:

  1. Executive Summary
  2. Non-Alcoholic Steatohepatitis Biomarkers Market Characteristics
  3. Non-Alcoholic Steatohepatitis Biomarkers Market Trends And Strategies
  4. Non-Alcoholic Steatohepatitis Biomarkers Market – Macro Economic Scenario
  5. Non-Alcoholic Steatohepatitis Biomarkers Market Size And Growth
  6. Non-Alcoholic Steatohepatitis Biomarkers Market Segmentation
  7. Non-Alcoholic Steatohepatitis Biomarkers Market Regional And Country Analysis

.

.

.

  1. Key Mergers And Acquisitions In The Non-Alcoholic Steatohepatitis Biomarkers Market
  2. Non-Alcoholic Steatohepatitis Biomarkers Market Future Outlook and Potential Analysis
  3. Appendix

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →